Skip to site menu Skip to page content

Deuterium-Containing Building Blocks for Drug Design

By Enamine

Selective incorporation of deuterium into organic molecules can profoundly alter their physical, chemical and biological properties.

Compared to hydrogen,deuterium displays a smaller molar volume (by 0.140 cm3/mol per atom), is less lipophilic (Δ logPoct = - 0.006) and might display a slightly different pKa. More importantly, C-D bonds are shorter (by 0.005 Å) and at times more stable to oxidative processes. This helps protect deuterated compounds from enzymatic degradation in the liver, increasing the compound’s half-life. In this context, Enamine offers a library of deuterium-containing building blocks for drug design.

We offer deuterium-containing building blocks from stock on a 5-10 g scale.

Design and full list you can find at MedChem Highlights section of Enamine’s website or in the white paper attachment on this page.

Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Related Content